Showing 63,821 - 63,840 results of 101,136 for search '(( 5 ((wt decrease) OR (nn decrease)) ) OR ( 5 ((a decrease) OR (mean decrease)) ))', query time: 1.91s Refine Results
  1. 63821

    Image_4_Epidemiological and demographic drivers of lung cancer mortality from 1990 to 2019: results from the global burden of disease study 2019.tif by Yaguang Fan (15415049)

    Published 2023
    “…Decomposition analysis was used to analyze the contributions of epidemiological and demographic drivers to lung cancer mortality.</p>Results<p>Despite a non-significant decrease in ASMR [EAPC = −0.31, 95% confidence interval (CI): −1.1 to 0.49], the number of deaths from lung cancer increased by 91.8% [95% uncertainty interval (UI): 74.5–109.0%] between 1990 and 2019. …”
  2. 63822

    Image_2_Epidemiological and demographic drivers of lung cancer mortality from 1990 to 2019: results from the global burden of disease study 2019.tif by Yaguang Fan (15415049)

    Published 2023
    “…Decomposition analysis was used to analyze the contributions of epidemiological and demographic drivers to lung cancer mortality.</p>Results<p>Despite a non-significant decrease in ASMR [EAPC = −0.31, 95% confidence interval (CI): −1.1 to 0.49], the number of deaths from lung cancer increased by 91.8% [95% uncertainty interval (UI): 74.5–109.0%] between 1990 and 2019. …”
  3. 63823

    Image_1_Epidemiological and demographic drivers of lung cancer mortality from 1990 to 2019: results from the global burden of disease study 2019.tif by Yaguang Fan (15415049)

    Published 2023
    “…Decomposition analysis was used to analyze the contributions of epidemiological and demographic drivers to lung cancer mortality.</p>Results<p>Despite a non-significant decrease in ASMR [EAPC = −0.31, 95% confidence interval (CI): −1.1 to 0.49], the number of deaths from lung cancer increased by 91.8% [95% uncertainty interval (UI): 74.5–109.0%] between 1990 and 2019. …”
  4. 63824
  5. 63825

    Thirty-year Trends in Complications in U.S. Adults With Newly Diagnosed Type 2 Diabetes by Michael Fang (9708234)

    Published 2021
    “…</p> <p><b>Results: </b>From 1988-1994 to 2011-2018, there was a significant decrease in the prevalence of albuminuria (38.9 to 18.7%, p-for-trend<0.001), but no change in the prevalence of reduced eGFR (7.5 to 9.9%, p-for-trend=0.30), retinopathy (1988-1994 to 1999-2008 only; 13.2 to 12.1%, p-for-trend=0.86), or self-reported cardiovascular disease (19.0 to 16.5%, p-for-trend=0.64). …”
  6. 63826

    Expression of Sox2, Sox10, Gata3, Prox1 and Peripherin during primary auditory neuron development and maturation. by Koji Nishimura (2077804)

    Published 2017
    “…At E10.5, Sox10 was downregulated as neuroblasts delaminated from the otocyst. …”
  7. 63827

    Evaluation of emerging NASH therapies: the impact of treatment efficacy profiles on long-term health outcomes: Supplementary materials by William L Herring (14039541)

    Published 2022
    “…The fibrosis worsening profile reduced predicted 10-year LRC rates (F1:</p> <p>1.9%; F2: 6.5%; F3: 19.1%; F4/CC: 55.0%) more than the resolution and fibrosis improvement profiles</p> <p>(F1: 2.6%/2.6%; F2: 8.5%/8.3%; F3: 23.3%/23.0%; F4/CC: NA/59.0%). …”
  8. 63828

    Secondary metabolites from <i>Gentiana cruciata</i> L. and their anti-inflammatory and analgesic activities by Rima Konya (14075753)

    Published 2023
    “…<p>A previously unreported secoiridoid glycoside, cruciatoside (<b>1</b>) was isolated from the aerial parts of <i>Gentiana cruciata</i> L. along with ten known compounds eustomoside (<b>2</b>), eustomorusside (<b>3</b>), gentiopicroside (<b>4</b>), 6'-<i>O</i>-β-D-glucopyranosyl gentiopicroside (<b>5</b>), loganic acid (<b>6</b>), isoorientin (<b>7</b>), isovitexin (<b>8</b>), isovitexin 2''<i>-(E)-</i>ferulate (<b>9</b>), mangiferin (<b>10</b>), and 2-methyl-inositol (<b>11</b>). …”
  9. 63829

    MPs<sup>PPARα+/+</sup>-induced EPC differentiation and <i>in vitro</i> angiogenesis of mature ECs involve NF-κB pathway activation. by Tarek Benameur (196206)

    Published 2010
    “…<p>(<b>A</b>) Western blot showing that MPs<sup>PPARα+/+</sup> induced I-κB phosphorylation on activator sites (Ser32/36) in EPCs, indicating that NF-κB pathway is activated. …”
  10. 63830

    DNMT1-mediated demethylation of lncRNA MEG3 promoter suppressed breast cancer progression by repressing Notch1 signaling pathway by Tingting Pan (4735617)

    Published 2022
    “…Functionally, treatment of breast cancer cells with the DNA methylation inhibitor 5-AzadC as well as silencing of DNA methyltransferase-1 (DNMT1) could decrease the abnormal hypermethylation of the MEG3 promoter, reverse MEG3 expression, inhibit cell proliferation and promote cell apoptosis. …”
  11. 63831

    Identification of Differentially-Expressed Genes Associated with Pistil Abortion in Japanese Apricot by Genome-Wide Transcriptional Analysis by Ting Shi (3955)

    Published 2012
    “…<div><p>The phenomenon of pistil abortion widely occurs in Japanese apricot, and imperfect flowers with pistil abortion seriously decrease the yield in production. Although transcriptome analyses have been extensively studied in the past, a systematic study of differential gene expression has not been performed in Japanese apricot. …”
  12. 63832

    Evolutionary dynamics of iPD-population consisting of two types of players: With WSLS and AllD strategies. by Anton M. Unakafov (5706560)

    Published 2020
    “…<p>(A) Initially, both types have the same frequency, but after 40 generations the fraction of WSLS-players <i>x</i><sub>1</sub>(<i>t</i>) converges to 0 for probabilities to see partner’s choice <i>p</i><sub>see</sub> = 0.0, 0.2 and to 1 for <i>p</i><sub>see</sub> = 0.4, 0.5. …”
  13. 63833

    Effect of Vitrification on the MicroRNA Transcriptome in Mouse Blastocysts by Xueming Zhao (400630)

    Published 2015
    “…Of these, the expression levels of five miRNAs differed significantly: in the vitrified blastocysts, four miRNAs (mmu-miR-199a-5p, mmu-miR-329-3p, mmu-miR-136-5p and mmu-miR-16-1-3p) were upregulated, and one (mmu-miR-212-3p) was downregulated. …”
  14. 63834

    FDG PET parameters and survival curves. by Julien Ganem (7490378)

    Published 2019
    “…<p>Survival curves using the Kaplan-Meier method. <b>(a)</b> PFS was longer for patients with low TLG<sub>2</sub> (HR = 2.8, 95%CI 1.3–5.9, p< 0.01). …”
  15. 63835

    Loss of FHL2 reduces intestinal polyp multiplicity. by Charlotte Labalette (365229)

    Published 2013
    “…<p>(A) Representative images of intestines from 11-month-old <i>Apc<sup>Δ14/+</sup>FHL2<sup>+/+</sup></i> and <i>Apc<sup>Δ14/+</sup>FHL2<sup>−/−</sup></i> mouse. …”
  16. 63836

    Comparison of two physiotherapy treatments in reducing pain and increasing functional autonomy of elderly patients with gonarthrosis by Stela Freitas Raymundo (12817830)

    Published 2022
    “…Similarly, there was significant decrease (p<0.001) in the level of pain in both EG1 (Δ=5.09) and EG2 (Δ=7.1). …”
  17. 63837

    Methylation profiling in control and Tet tcKO retinas. Related to Fig 6. by Ismael Hernández-Núñez (10128242)

    Published 2025
    “…<p><b>(A)</b> Graphic displaying results of WGBS and bACE-seq to distinguish 5mC and 5hmC marks. …”
  18. 63838
  19. 63839
  20. 63840